
HALO
USDHalozyme Therapeutics Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$67.640
High
$69.910
Low
$65.000
Volume
0.89M
Company Fundamentals
Market Cap
8.0B
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
2.09M
Exchange
NMS
Currency
USD
52-Week Range
Related News
JP Morgan Maintains Neutral on Halozyme Therapeutics, Raises Price Target to $65
JP Morgan analyst Jessica Fye maintains Halozyme Therapeutics with a Neutral and raises the price target from $63 to $65.
HC Wainwright & Co. Reiterates Buy on Halozyme Therapeutics, Maintains $90 Price Target
HC Wainwright & Co. analyst Mitchell S. Kapoor reiterates Halozyme Therapeutics with a Buy and maintains $90 price target.
Leerink Partners Upgrades Halozyme Therapeutics to Market Perform, Announces $70 Price Target
Leerink Partners analyst David Risinger upgrades Halozyme Therapeutics from Underperform to Market Perform and announces $70 price target.
Related Stocks
TME
Tencent Music Entertainment Group American Depositary Shares each representing two Ordinary Shares
RUSHB
Rush Enterprises Inc.
SGMO
Sangamo Therapeutics Inc.
MAS
Masco Corporation
CLM
Cornerstone Strategic Value Fund Inc. New
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.